grant
Targeted Disruption of MDM2 Dimerisation as a Novel Approach to Treating High-Risk Neuroblastoma
Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Description preview
Accounting for greater than 20% of neonatal cancers, neuroblastoma (NB) represents the most common extracranial paediatric malignancy [1]. An embryonal tumour, NB arises from the sympathetic nervous system and is responsible for 15% of paediatric cancer mortality. Despite significant advances in NB diagnosis and treatment, high-risk NB (i.e.,…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click